Matches in SemOpenAlex for { <https://semopenalex.org/work/W4382787617> ?p ?o ?g. }
- W4382787617 abstract "Adoptive transfer of natural killer (NK) cells represents a viable treatment method for patients with advanced malignancies. Our team previously developed a simple, safe, and cost-effective method for obtaining high yields of pure and functional NK cells from cord blood (CB) without the need for cell sorting, feeder cells, or multiple cytokines. We present the case of a 52-year-old female patient diagnosed with poorly differentiated stage IVB (T3N2M1) endometrial cancer, who exhibited leukemoid reaction and pretreatment thrombocytosis as paraneoplastic syndromes. The patient received two courses of CB-derived NK (CB-NK) cell immunotherapy between March and September 2022, due to her extremely low NK cell activity. Two available CB units matched at 8/10 HLA with KIR-mismatch were chosen, and we were able to produce NK cells with high yield (>1.0×10 10 NK cells), purity (>90%), and function (>80%) from CB without cell sorting, feeder cells, or multiple cytokines. These cells were then adoptively transferred to the patient. No adverse effects or graft-versus-host disease were observed after infusion of CB-NK cells. Our clinical experience supports the efficacy of CB-NK cell treatment in increasing NK cell activity, depleting tumor activity, improving quality of life, and reducing the size of abdominal and pelvic masses with the disappearance of multiple lymph node metastases through the regulation of systemic antitumor immunity. Remarkably, the white blood cell and platelet counts decreased to normal levels after CB-NK cell immunotherapy. This clinical work suggests that CB-NK cell immunotherapy holds promise as a therapeutic approach for endometrial cancer." @default.
- W4382787617 created "2023-07-02" @default.
- W4382787617 creator A5028067869 @default.
- W4382787617 creator A5042304706 @default.
- W4382787617 creator A5046548838 @default.
- W4382787617 creator A5054370704 @default.
- W4382787617 creator A5056075106 @default.
- W4382787617 date "2023-06-30" @default.
- W4382787617 modified "2023-10-18" @default.
- W4382787617 title "Case Report: Cord blood-derived natural killer cells as new potential immunotherapy drug for solid tumor: a case study for endometrial cancer" @default.
- W4382787617 cites W1919577144 @default.
- W4382787617 cites W1964627229 @default.
- W4382787617 cites W2146494327 @default.
- W4382787617 cites W2147068163 @default.
- W4382787617 cites W2165813814 @default.
- W4382787617 cites W2332619013 @default.
- W4382787617 cites W2599506479 @default.
- W4382787617 cites W2613870572 @default.
- W4382787617 cites W2738412015 @default.
- W4382787617 cites W2808394110 @default.
- W4382787617 cites W2912218228 @default.
- W4382787617 cites W2940517335 @default.
- W4382787617 cites W2946946191 @default.
- W4382787617 cites W2990608171 @default.
- W4382787617 cites W3046958019 @default.
- W4382787617 cites W3089070233 @default.
- W4382787617 cites W3094296829 @default.
- W4382787617 cites W3119838003 @default.
- W4382787617 cites W3146284903 @default.
- W4382787617 cites W3155512942 @default.
- W4382787617 cites W3189783014 @default.
- W4382787617 cites W3194477856 @default.
- W4382787617 cites W3215593750 @default.
- W4382787617 cites W4207058776 @default.
- W4382787617 cites W4221018141 @default.
- W4382787617 cites W4225873358 @default.
- W4382787617 cites W4281826746 @default.
- W4382787617 cites W4295845785 @default.
- W4382787617 doi "https://doi.org/10.3389/fimmu.2023.1213161" @default.
- W4382787617 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37457710" @default.
- W4382787617 hasPublicationYear "2023" @default.
- W4382787617 type Work @default.
- W4382787617 citedByCount "0" @default.
- W4382787617 crossrefType "journal-article" @default.
- W4382787617 hasAuthorship W4382787617A5028067869 @default.
- W4382787617 hasAuthorship W4382787617A5042304706 @default.
- W4382787617 hasAuthorship W4382787617A5046548838 @default.
- W4382787617 hasAuthorship W4382787617A5054370704 @default.
- W4382787617 hasAuthorship W4382787617A5056075106 @default.
- W4382787617 hasBestOaLocation W43827876171 @default.
- W4382787617 hasConcept C121608353 @default.
- W4382787617 hasConcept C126322002 @default.
- W4382787617 hasConcept C129374314 @default.
- W4382787617 hasConcept C154317977 @default.
- W4382787617 hasConcept C202751555 @default.
- W4382787617 hasConcept C203014093 @default.
- W4382787617 hasConcept C2776090121 @default.
- W4382787617 hasConcept C2777088508 @default.
- W4382787617 hasConcept C2777701055 @default.
- W4382787617 hasConcept C2778102761 @default.
- W4382787617 hasConcept C2780849966 @default.
- W4382787617 hasConcept C28651165 @default.
- W4382787617 hasConcept C502942594 @default.
- W4382787617 hasConcept C55493867 @default.
- W4382787617 hasConcept C71924100 @default.
- W4382787617 hasConcept C86803240 @default.
- W4382787617 hasConcept C8891405 @default.
- W4382787617 hasConceptScore W4382787617C121608353 @default.
- W4382787617 hasConceptScore W4382787617C126322002 @default.
- W4382787617 hasConceptScore W4382787617C129374314 @default.
- W4382787617 hasConceptScore W4382787617C154317977 @default.
- W4382787617 hasConceptScore W4382787617C202751555 @default.
- W4382787617 hasConceptScore W4382787617C203014093 @default.
- W4382787617 hasConceptScore W4382787617C2776090121 @default.
- W4382787617 hasConceptScore W4382787617C2777088508 @default.
- W4382787617 hasConceptScore W4382787617C2777701055 @default.
- W4382787617 hasConceptScore W4382787617C2778102761 @default.
- W4382787617 hasConceptScore W4382787617C2780849966 @default.
- W4382787617 hasConceptScore W4382787617C28651165 @default.
- W4382787617 hasConceptScore W4382787617C502942594 @default.
- W4382787617 hasConceptScore W4382787617C55493867 @default.
- W4382787617 hasConceptScore W4382787617C71924100 @default.
- W4382787617 hasConceptScore W4382787617C86803240 @default.
- W4382787617 hasConceptScore W4382787617C8891405 @default.
- W4382787617 hasFunder F4320321001 @default.
- W4382787617 hasFunder F4320322868 @default.
- W4382787617 hasLocation W43827876171 @default.
- W4382787617 hasLocation W43827876172 @default.
- W4382787617 hasLocation W43827876173 @default.
- W4382787617 hasOpenAccess W4382787617 @default.
- W4382787617 hasPrimaryLocation W43827876171 @default.
- W4382787617 hasRelatedWork W1607248340 @default.
- W4382787617 hasRelatedWork W1965332838 @default.
- W4382787617 hasRelatedWork W1996150995 @default.
- W4382787617 hasRelatedWork W1996522617 @default.
- W4382787617 hasRelatedWork W2140647949 @default.
- W4382787617 hasRelatedWork W2154561989 @default.
- W4382787617 hasRelatedWork W2772196220 @default.
- W4382787617 hasRelatedWork W3029595077 @default.
- W4382787617 hasRelatedWork W4360983034 @default.